The meanings of markers: Ancillary techniques in diagnosis of thyroid neoplasia

被引:40
作者
Raphael, SJ
机构
[1] Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Pathol, Toronto, ON, Canada
[2] Univ Toronto, Dept Pathobiol & Lab Med, Toronto, ON, Canada
关键词
thyroid; neoplasia; immunohistochemistry; cytokeratins; galectin-3; HBME-1;
D O I
10.1385/EP:13:4:301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This review article primarily discusses immunohistochemical markers used to aid the diagnosis of thyroid neoplasia. The review concentrates on high molecular weight cytokeratins, cytokertain 19, HBME-1, and galectin-3. Diagnostic uses of proliferation markers such as p27(kip1) and Ki-67 are discussed along with the oncogene ret in relation to papillary carcinomas and PAX8-peroxisome proliferator-activated receptor gamma1 in relation to follicular carcinoma. The diagnostic use of retinoblastoma tumor suppressor gene product is also discussed. The sensitivities and specificities as well as the pitfalls of these techniques are reviewed. On the basis of the literature, the most highly recommended of these markers to aid in diagnosis are HBME-1 and galectin-3.
引用
收藏
页码:301 / 311
页数:11
相关论文
共 34 条
[1]  
[Anonymous], 1990, Surgical pathology of the thyroid
[2]   Retinoblastoma expression in thyroid neoplasms [J].
Anwar, F ;
Emond, MJ ;
Schmidt, RA ;
Hwang, HC ;
Bronner, MP .
MODERN PATHOLOGY, 2000, 13 (05) :562-569
[3]   Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions [J].
Bartolazzi, A ;
Gasbarri, A ;
Papotti, M ;
Bussolati, G ;
Lucante, T ;
Khan, A ;
Inohara, H ;
Marandino, F ;
Orlandi, F ;
Nardi, F ;
Vecchione, A ;
Tecce, R ;
Larsson, O .
LANCET, 2001, 357 (9269) :1644-1650
[4]   Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer [J].
Cheung, CC ;
Carydis, B ;
Ezzat, S ;
Bedard, YC ;
Asa, SL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (05) :2187-2190
[5]   Immunohistochemical diagnosis of papillary thyroid carcinoma [J].
Cheung, CC ;
Ezzat, S ;
Freeman, JL ;
Rosen, IB ;
Asa, SL .
MODERN PATHOLOGY, 2001, 14 (04) :338-342
[6]  
Cvejic D, 1998, ANTICANCER RES, V18, P2637
[7]   Cloning and characterization of the thyroid iodide transporter [J].
Dai, G ;
Levy, O ;
Carrasco, N .
NATURE, 1996, 379 (6564) :458-460
[8]   Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid [J].
Erickson, LA ;
Jin, L ;
Goellner, JR ;
Lohse, C ;
Pankratz, VS ;
Zukerberg, LR ;
Thompson, GB ;
van Heerden, JA ;
Grant, CS ;
Lloyd, RV .
MODERN PATHOLOGY, 2000, 13 (02) :186-192
[9]  
Erickson LA, 1998, MODERN PATHOL, V11, P169
[10]   p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma [J].
Erickson, LA ;
Yousef, OM ;
Jin, L ;
Lohse, CM ;
Pankratz, VS ;
Lloyd, RV .
MODERN PATHOLOGY, 2000, 13 (09) :1014-1019